Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent

Launched by JUNG-MIN AHN · Sep 6, 2021

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness and safety of two types of stents, called Synergy XD and Synergy Megatron™, which are used to treat coronary artery disease and related heart conditions. The goal is to see how well these stents work in everyday medical practice compared to other similar devices. Researchers are currently looking for participants, so if you are 19 years or older and are receiving one of these stents, you may be eligible to join the study.

To participate, you need to agree to follow the study's guidelines and provide written consent. However, if you have a mix of different types of stents, a serious illness with a life expectancy of less than one year, or are in a state of cardiogenic shock (a severe heart condition), you won't be able to participate. If you join the trial, you can expect to follow a schedule for check-ups to monitor your health after receiving the stent. This study aims to provide valuable information to improve heart care for patients like you.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients ≥ 19 years old
• • Patients receiving Synergy XD stent(s) or Synergy Megatron™ stent(s).
• • The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
• Exclusion Criteria:
• • Patients with a mixture of other drug-eluting stents (DESs)
• • Terminal illness with life-expectancy ≤1 year.
• • Patients with cardiogenic shock